Fortitude Family Office’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1
Closed -$10 1979
2025
Q3
$10 Sell
1
-2
-67% -$21 ﹤0.01% 1974
2025
Q2
$30 Buy
+3
New +$32 ﹤0.01% 2021

Other funds holding DVAX

Fortitude Family Office's DVAX Position: Q4 2025 in Review

Fortitude Family Office sold out of Dynavax Technologies (DVAX) in Q4 2025, closing a stake of 1 share — an estimated $10 sold.

Fortitude Family Office first reported a position in DVAX in Q2 2025 and held it in 2 quarters. The position peaked at $30 in Q2 2025. 266 funds tracked by Wall St. Rank hold DVAX as of Q4 2025.

  • Fortitude Family Office reported no remaining Dynavax Technologies position as of Q4 2025 after selling out during the quarter.
  • Fortitude Family Office sold 1 Dynavax Technologies share in Q4 2025, an estimated $10.
  • Fortitude Family Office first reported a position in Dynavax Technologies in Q2 2025 and held it in 2 quarters.
  • Fortitude Family Office's Dynavax Technologies position peaked at $30 in Q2 2025.
  • 266 funds tracked by Wall St. Rank held Dynavax Technologies as of Q4 2025.

Based on Fortitude Family Office's 13F filing for Q4 2025, filed 15 Jan 2026.